CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Biogen Inc 's Total Debt to Equity for Trailing Twelve Months Period

BIIB's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

BIIB Total Debt to Equity for Trailing Twelve Months Period

(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Equity Growth -19.89 % -23.21 % -12.82 % -9.3 % 2.36 %
Y / Y Total Debt Growth 24.71 % 24.72 % 24.8 % 0.31 % 0.31 %
Total Debt to Equity for Trailing Twelve Months Period 0.62 0.56 0.49 0.45 0.44
Total Ranking # 878 # 1254 # 1492 # 1433 # 1256
Seq. Equity Growth -0.54 % -4.82 % -9.95 % -6.01 % -4.66 %
Seq. Total Debt Growth 0.02 % 0.02 % 24.52 % 0.12 % 0.02 %


Total Debt to Equity for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to net new borrowings of 0.02%, Total Debt to Equity for Trailing Twelve Months Period improved to 0.62, above Biogen Inc 's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Drugs industry 31 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Biogen Inc . While Total Debt to Equity for Trailing Twelve Months Period total ranking has improved so far to 878, from total ranking in previous quarter at 1254.

What is Debt to Equity Ratio?
BIIB Charts and Quotes
Total Debt to Equity BIIB in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 32
Sector # 154
S&P 500 # 877


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.35 0.09 0
(March 31, 2008)   (Dec 31 2018)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Dec 31 2020, within Biotechnology & Drugs Industry Total Debt to Equity for Trailing Twelve Months Period
Navidea Biopharmaceuticals Inc   1.63 
Reynolds Consumer Products Inc   1.55 
Aptevo Therapeutics Inc   1.53 
Bionano Genomics Inc   1.41 
Gilead Sciences Inc   1.36 
Coherus Biosciences inc   1.32 
Eargo Inc   1.31 
Adma Biologics Inc   1.28 
Nanostring Technologies Inc   1.21 
Neuronetics Inc   0.98 
Genocea Biosciences Inc   0.81 
Acorda Therapeutics inc   0.77 
Emergent Biosolutions Inc   0.69 
Qiagen N v   0.67 
Quotient Limited  0.67 
Soligenix Inc   0.66 
Cellular Biomedicine Group Inc   0.64 
Neurocrine Biosciences Inc   0.60 
Royalty Pharma Plc  0.59 
Predictive Oncology Inc   0.57 
Biogen Inc   0.57 
Allena Pharmaceuticals Inc   0.56 
Sunwin Stevia International Inc   0.56 
Eloxx Pharmaceuticals Inc   0.56 
Integrated Biopharma Inc  0.55 
Evelo Biosciences Inc   0.55 
Establishment Labs Holdings Inc   0.52 
Cyanotech Corp  0.46 
Eiger Biopharmaceuticals Inc   0.43 
Tg Therapeutics inc   0.42 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FUNC's Profile

Stock Price

FUNC's Financials

Business Description

Fundamentals

Charts & Quotes

FUNC's News

Suppliers

FUNC's Competitors

Customers & Markets

Economic Indicators

FUNC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071